Report Sccope & Overview:
The 3D Printing Medical Devices Market Size was valued at USD 3.12 billion in 2022 and is expected to reach USD 5.70 billion by 2030, and grow at a CAGR of 7.8% over the forecast period 2023-2030.
In the manufacture of medical and dental devices, 3D printing medical device plays an extremely important role. Due to various capabilities, 3D printers are most commonly used for medical devices, but they may also be used for other items such as food, household items, and automobile parts. This 3D printing technology is used to treat a variety of conditions, including titanium hip and jaw replacements, appendage prostheses, and plastic tracheal supports, among others. Many experts choose 3D printing devices before medical treatments of any organ part because of cutting-edge innovation and uncomplicated devices, which can reduce errors.
To get more information on 3D Printing Medical Devices Market - Request Sample Report
A Computer plan drawing or an imaging technique picture is a 3D product shaped from an advanced 3D picture. The 3D thing is created by building up continuous layers of material, which are connected to the previous layer until the object is complete. Various sorts of materials are used to create a 3D image that is effective for medical applications.
The 3D Printing Medical Devices Market is expected to grow as a result of rising government investment in the medical care sector, technological advancements in 3D printing, easy development of medical devices, and increased use of 3D printing devices in the clinical services industry. In the healthcare and dental assembly business, 3D printing has become a vital tool. Clinical device producers choose it for a variety of reasons, including amplifiers, prosthetics, and custom-made knee and hip embeds. Because of several technical breakthroughs in this sector, the 3D Printing Medical Devices Industry is expected to demonstrate significant growth during the forecasted time range. Furthermore, many factors such as R&D investment, rapidly expanding customer base, and Increase the scope of biomedical applications have fueled the growth of the 3D Printing Medical Devices market.
Increasing the public-private partnership's funding
Ability to conduct research and development
Infrastructure for healthcare is expanding.
Due to a lack of specialized training,
Skilled labor shortage.
Direct digital production.
Shifting towards advanced medical treatment.
High Investment and operating cost.
Lack of awareness.
Lack of acceptable reimbursement scenarios
IMPACT OF COVID-19
Due to the pandemic, admission to customers to sell and carry out 3D Printing Medical Devices declined during March 2020 and the second quarter of 2020, as emergency departments were mostly focused on the COVID-19 pandemic. The pandemic has sparked a major surge in demand for ventilators. The closure of assembling offices due to lockdowns and disrupted supply chains had a minor impact on the regional development of the 3D Printing Medical Devices Market in 2020.
The market for 3D printing medical devices is divided into three categories: equipment, materials, and software and services. The 3D Printing Medical Devices market was dominated by software and services. The cost-effectiveness, utility, consistency, and precision of medical device 3D printing services are likely to drive this segment's expansion over the forecast period.
Electron beam melting (EBM), laser beam melting (LBM), photopolymerization, droplet deposition or extrusion-based technologies, three-dimensional printing (3DP) or adhesion bonding, and other technologies make up the 3D printing medical devices market. The laser beam melting (LBM) segment had the biggest market share. The growing use of this technology in the dental industry and for manufacturing implants for minimally invasive surgery is responsible for the huge proportion of this market.
Surgical guides, surgical tools, conventional prosthetics and implants, custom prosthetics and implants, tissue-engineered goods, hearing aids, wearable medical devices/implantable medical devices, and other medical equipment make up the 3D printing medical devices market. In 2020, the custom prosthetics and implants category held a higher part of the market. 3D printing is widely used to create highly customizable prosthetics and implants from a wide range of materials, including biological materials (such as skin and bones), plastics, ceramics, and metals. 3D printing of custom implants is drawing many medical device businesses and new investors to purchase 3D printers. This market segment is predicted to grow rapidly in the future years.
Hospitals and surgical centers, dentistry and orthopedic clinics, academic institutions and research laboratories, pharma-biotech and medical device firms, and clinical research organizations make up the 3D Printing Medical Devices market. In 2020, the hospital and surgical center category accounted for the greatest proportion of the market. The growth of existing 3D printing laboratories, the increasing affordability of 3D printing services, and hospitals' quick embrace of sophisticated technologies are all contributing to this segment's big share.
KEY MARKET SEGMENTS:
Laser Beam Melting
Electron Beam Melting
Three-dimensional Printing /Binder Jetting
Services & Software
Standard Prosthetics & Implants
Custom Prosthetics & Implants
By End User
Hospitals & Surgical Centers
Academic Institutions & Research Laboratories
Dental & Orthopedic Clinics
Clinical Research Organizations
Pharma-Biotech & Medical Device Companies
Need any customization research on 3D Printing Medical Devices Market - Enquiry Now
The Asia-Pacific, Americas, Europe, the Middle East, and Africa 3D Printing Medical Devices Market has been segmented into distinct regions. The 3D Printing Medical Devices Market in the Americas has also been segmented into North America and South America, with the former divided into the United States and Canada. Western Europe and Eastern Europe are the two halves of the European 3D Printing Medical Devices Industry.
Rest of Europe
Rest of Asia-Pacific
The Middle East & Africa
Rest of Middle East & Africa
Rest of Latin America
Some of the major key players are: 3D Systems Corporations, Cyfuse Medical K.K., Stratasys Ltd., EOS GmbHConcept, 3T RPD Ltd., Prodways Group, Oxford Performance Materials, Inc., SLM Solutions Group AG, Arcam AB, EnvisionTEC, Organovo Holdings, Inc., Bio3D Technologies, Renishawplc, Materialise NV, Laser GmbH, and Other Players.
Cyfuse Medical K.K-Company Financial Analysis
|Market Size in 2022||US$ 3.12 Billion|
|Market Size by 2030||US$ 5.70 Billion|
|CAGR||CAGR of 7.8% From 2023 to 2030|
|Report Scope & Coverage||Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook|
|Key Segments||• By Technology (Laser Beam Melting, Electron Beam Melting, Photopolymerization, Droplet Deposition, Three-dimensional Printing /Binder Jetting, Other Technologies)
• By Component (Materials, Equipment, Services & Software)
• By Application (Standard Prosthetics & Implants, Custom Prosthetics & Implants, Wearable Medical Devices, Surgical Instruments, Tissue-engineered Products, Surgical Guides, Hearing Aids, Other Applications)
• By End User (Hospitals & Surgical Centers, Academic Institutions & Research Laboratories, Dental & Orthopedic Clinics, Clinical Research Organizations, Pharma-Biotech & Medical Device Companies)
|Regional Analysis/Coverage||North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
|Company Profiles||3D Systems Corporations, Cyfuse Medical K.K., Stratasys Ltd., EOS GmbHConcept, 3T RPD Ltd., Prodways Group, Oxford Performance Materials, Inc., SLM Solutions Group AG, Arcam AB, EnvisionTEC, Organovo Holdings, Inc., Bio3D Technologies, Renishawplc, Materialise NV, Laser GmbH, and Other Players.|
|DRIVERS||• Increasing the public-private partnership's funding
• Ability to conduct research and development
• Infrastructure for healthcare is expanding.
|RESTRAINTS||• Due to a lack of specialized training,
• Skilled labor shortage.
Ans:- The 3D Printing Medical Devices Market Size was valued at USD 3.12 billion in 2022.
3D Systems Corporations, Cy fuse Medical K.K., Stratasys Ltd., EOS GmbH Concept, 3T RPD Ltd., Prod ways Group, Oxford Performance Materials, Inc., SLM Solutions Group AG, Arcam AB are the key players of the 3D Printing Medical Devices Market.
Ans:- The 3D Printing Medical Devices Market is growing at a CAGR of 7.8% over the forecast period 2023-2030.
Increasing the public-private partnership's funding, Ability to conduct research and development, are all propelling the 3D Printing Medical Devices market forward.
Due to a lack of specialized training, and Skilled labor shortage are the main restraints of the Medical Nonwoven Disposable market.
Table of Contents
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.2 Impact on major economies
184.108.40.206 United Kingdom
220.127.116.11 South Korea
18.104.22.168 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. 3D Printing Medical Devices Market Segmentation, By Technology
8.1 Laser Beam Melting
8.2 Electron Beam Melting
8.4 Droplet Deposition
8.5 Three-dimensional Printing /Binder Jetting
8.6 Other Technologies
9. 3D Printing Medical Devices Market Segmentation, By Component
9.3 Services & Software
10. 3D Printing Medical Devices Market Segmentation, By Application
10.1 Standard Prosthetics & Implants
10.2 Custom Prosthetics & Implants
10.3 Wearable Medical Devices
10.4 Surgical Instruments
10.5 Tissue-engineered Products
10.6 Surgical Guides
10.7 Hearing Aids
10.8 Other Applications
11. 3D Printing Medical Devices Market Segmentation, By End User
11.1 Hospitals & Surgical Centers
11.2 Academic Institutions & Research Laboratories
11.3 Dental & Orthopedic Clinics
11.4 Clinical Research Organizations
11.5 Pharma-Biotech & Medical Device Companies
12. Regional Analysis
12.2 North America
12.3.6 The Netherlands
12.3.7 Rest of Europe
12.4.2 South Korea
12.4.6 Rest of Asia-Pacific
12.5 The Middle East & Africa
12.5.3 South Africa
12.6 Latin America
12.6.3 Rest of Latin America
13. Company Profiles
13.1 3D Systems Corporations
13.1.2 Products/ Services Offered
13.1.3 SWOT Analysis
13.1.4 The SNS view
13.2 Cyfuse Medical K.K.
13.3 Stratasys Ltd.
13.4 EOS GmbHConcept
13.5 3T RPD Ltd.
13.6 Prodways Group
13.7 Oxford Performance Materials, Inc.
13.8 SLM Solutions Group AG
13.9 Arcam AB
13.11 Organovo Holdings, Inc.
13.12 Bio3D Technologies
13.14 Materialise NV
13.15 Laser GmbH
14. Competitive Landscape
14.1 Competitive Benchmark
14.2 Market Share Analysis
14.3 Recent Developments
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Nanomedicine Market Size was valued at USD 170.47 billion in 2022, and is expected to reach USD 431.21 billion by 2030 and grow at a CAGR of 12.3% over the forecast period 2023-2030.
The Advanced Visualization Market Size was valued at USD 3.64 billion in 2022 and is expected to reach USD 8.78 billion by 2030 and grow at a CAGR of 11.6% over the forecast period 2023-2030.
The Omega 3 supplements market was valued USD 6.60 billion in 2022 and is estimated to reach USD 12.96 billion by 2030. From 2023 to 2030 & grow at a CAGR of 8.8%.
The Nano Biotechnology Market Size was valued at USD 6.48 billion in 2022, and is expected to reach USD 13.79 billion by 2030 and grow at a CAGR of 9.9% over the forecast period 2023-2030.
The Biopharmaceutical CMO Market size was valued at USD 30.22 billion in 2022 and is expected to reach at USD 79.77 billion by 2030, and grow at a CAGR of 12.9% over the forecast period of 2023-2030.
Hi! Click one of our member below to chat on Phone